Christopher Thomas Giordano
Christopher Thomas Giordano has made 1 open-market purchase worth $20k since Sep 16, 2026, in 1 company. The latest: $20k of TENX, filed Sep 16, 2026, scored 44 out of 100.
CEO, TENAX THERAPEUTICS, INC.
Follow Christopher Thomas Giordano, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 16 Form 4 (opens sec.gov) |
TENXTENAX THERAPEUTICS, INC. · CEOCEO · Near 52-week low · Penny stock: hard to trade | +96% stake | 44 | $20k 10,850 at $1.85 |
— | — |
Questions
What stock has Christopher Thomas Giordano bought?
TENX (TENAX THERAPEUTICS, INC.), all on the open market and reported on SEC Form 4.
When did Christopher Thomas Giordano last buy?
Sep 16, 2026: 10,850 shares of TENX at $1.85, $20k in all (Form 4 (opens sec.gov)).
Has Christopher Thomas Giordano filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Christopher Thomas Giordano a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 16, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer